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A b s t r a c t
Introduction: Immunoglobulin A nephropathy (IgAN) may lead to end stage 
renal disease and severely affect patient functioning and wellbeing. The aim 
of the study was to evaluate health-related quality of  life (HRQoL) in chil-
dren and adolescents with IgAN, and compare HRQoL in relation to the dis-
ease course, social status and psychological factors, such as expressing an-
ger and perceived personal competence.
Material and methods: The multicentre cross-sectional study included 51 pa-
tients ≥ 8 years from 7 paediatric nephrology centres in Poland. Psychomet-
ric analysis was performed using the  Kidscreen-52 questionnaire to evaluate 
HRQoL, the Anger Expression Scale to evaluate the severity of anger and the Per-
sonal Competence Scale to measure general perception of personal competence.
Results: Mean age of patients was 14.54 ±3.69 years; duration since the dia-
gnosis of IgAN was 4.98 ±3.9 years. Patients with IgAN rated their psychologi-
cal wellbeing as significantly worse compared to healthy peers (p < 0.05). The 
presence of proteinuria was associated with significantly worse physical well-
being (58.72 ±18.45 vs. 74.44 ±22.97; p < 0.05). Current therapy (steroids/im-
munosuppressive drugs) had no effect on HRQoL in the study group. Perceived 
personal competence was rated high by 49% of children in the study group. 
Children with IgAN were characterized by lower intensity of expressed anger 
(p < 0.001) and significantly higher intensity of suppressed anger (p < 0.01) 
compared to reference ranges. Severity of  expressed anger correlated posi-
tively with the parent relations and school environment dimensions of HRQoL.
Conclusions: We found lower HRQoL in regard to physical and psychological 
wellbeing in a group of Polish children with IgAN compared to healthy peers. 
HRQoL should be monitored in this patient group. 
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Introduction
Immunoglobulin A nephropathy (IgAN) is a form 
of  chronic glomerulonephritis which is currently 
considered the  most common primary glomeru-
lopathy worldwide, leading to renal failure in 20–
50% of adult patients at 20 years. In the paediatric 
population, end-stage renal disease (ESRD) was 
shown to develop in 11% of patients at 15 years [1]. 
Depending on the  severity of  clinical symptoms 
and histopathological findings, glucocorticoste-
roids and immunosuppressive drugs may be used 
in the  treatment of  IgAN. Similarly to any chro-
nic disease, IgAN may affect patient functioning 
and wellbeing due to the  limitations it imposes. 
IgA nephropathy in the paediatric population af-
fects mostly school-age children and adolescents, 
which means that a  chronic disease becomes 
an  additional burden during the  key develop-
mental period which is already psychologically 
challenging by itself. Health-related quality of life 
(HRQoL), a  parameter describing human wellbe-
ing in relation to health-related factors (physical, 
mental, and social health), is currently considered 
an important factor indicating a therapeutic suc-
cess in chronic disease and a predictor of patient 
morbidity and mortality. Tools to evaluate HRQoL 
in adult patients are well established, while appro-
priate psychometric tools in the paediatric popu-
lation have only been developed during the  last 
decade. In IgAN, both the disease course with pe-
riods of remission and exacerbation and the need 
for hospitalization, and the treatment used, lead-
ing to isolation from peers and a change in body 
physique, may be factors that have a significant 
negative effect on the  patient’s quality of  life. 
Available literature lacks data on HRQoL in chil-
dren with IgAN.
In our study, we attempted to evaluate: (1) HRQoL 
in children and adolescents with IgAN compared 
to the reference Polish population of healthy chil-
dren, (2) the effect of social factors on HRQoL in 
the study group, and (3) personal competence and 
severity and expression of anger as factors affect-
ing patient’s self-perception and health-related 
behaviours, which may be important in the con-
text of future medical care following transition to 
adulthood.
Material and methods
This multicentre cross-sectional study included 
51 of 140 patients in the Polish IgAN Registry (2000–
2015) in whom the disease developed in childhood. 
The  patients were under the  care of  7 paediatric 
nephrology centres in Poland.
Inclusion criteria were: patient age ≥ 8 years, no 
disease exacerbation during the last 3 months, and 
written informed consent for study participation. 
We excluded mentally retarded children and those 
with the duration of kidney disease < 6 months. 
The study was approved by the bioethics commit-
tee at the Medical University of Warsaw. 
Psychometric analysis was performed using 
the following tools:
1) Kidscreen-52 questionnaire – a  Polish ver-
sion of  the  universal European questionnaire 
to evaluate HRQoL in children and adolescents. 
This tool has been developed for children aged 
8–18 years, healthy or suffering from disease. It 
measures ten dimensions of HRQoL: (1) physical 
well-being, mental health as evaluated in three di-
mensions: (2) psychological well-being, (3) moods 
and emotions, and (4) self-perception, and so-
cial functioning as evaluated in five dimensions: 
(5) autonomy, (6) parent relations and home 
life, (7) social support and peers, (8) school en-
vironment, (9) social acceptance (bullying), and 
(10) financial resources. Questions are answered 
using standardized 5-grade evaluation regarding 
frequency (never, seldom, quite frequently, fre-
quently, always) or intensity (not at all, slightly, 
moderately, much, very much). The  results were 
shown as the  overall score from 0 to 100. This 
questionnaire was validated in the  population 
of  Polish children and adolescents (healthy and 
with chronic illnesses) and reference ranges were 
developed for age- and gender-stratified groups. 
The  instrument can be used as a generic instru-
ment to assess quality of life in children and ado-
lescents with a chronic illness [2]. 
2) Anger Expression Scale (Skala Ekspresji Gniewu, 
SEG) [3] – a  tool to evaluate the  severity of  an-
ger and its expression in common situations. It 
is a  universal tool which can be used for both 
healthy and ill children. This tool has been de-
veloped for children aged 11–17 years. It includes 
20 items scored from 1 (never) to 5 (always), 
grouped in two subscales of 10 items each related 
to expressed and suppressed anger. The  overall 
score is the sum of scores for individual items, cal-
culated separately for expressed and suppressed 
anger. The results are compared to the mean nor-
malized values stratified for age, gender, and so-
cial background. Raw results are transformed to 
standardized units (stens), where 1–4 stens indi-
cate low intensity of anger, and 7–10 stens indi-
cate high intensity of anger.
3) Personal Competence Scale (Skala Kompe-
tencji Osobistej, KompOs) [4] developed by Zygfryd 
Juczyński – a scale measuring general perception 
of  personal competence grouped into subscales 
A and B. Subscale A measures perceived strength 
necessary to initiate actions, and subscale B mea-
sures persistence in continuing actions. Each sub-
scale includes 6 items with 4 possible answers. 
Each item is scored from 1 to 4, each subscale 
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from 6 to 24, and the overall score ranges from 
12 to 48, with higher values indicating higher per-
ceived personal competence, strength and per-
sistence. Upon transformation to standardized 
Table I. Clinical characteristics of the study group
Parameter Study group (n = 51)
Age at disease onset [years] 9.79 ±4.36




Body mass index [kg/m2] 21.87 (13.87–30.42)
Area of residence, n (%):
Rural 22 (43.14)
Urban 29 (56.86)
Education level of the primary caretaker, n (%):
Vocational 10 (19.61)
High school 20 (39.22)
University level 15 (29.41)
No data 6 (11.76)
Employment of the primary caretaker, n (%):
Yes 33 (64.71)
No 17 (33.33)
No data 1 (1.96)
Family model, n (%):
Traditional 45 (88.24)
Mother + children 4 (7.8)
Mother + partner 1 (1.96)
No data 1 (1.96)
Mode of education, n (%):
Regular schooling 44 (86.28)
Individualized education at 
school
4 (7.84)




Proteinuria, n (%) 39 (76.49)
Hypertension, n (%) 13 (25.5)
Past steroid treatment, n (%) 36 (70.59)




units (stens), 1–4 stens (overall score 12–30) are 
rated low, and 7–10 stens (overall score 37–48) are 
rated high. This tool has been developed for group 
and individual evaluation of children and adoles-
cents in conditions of health and disease. Internal 
consistency (Cronbach’s a) is 0.74, and reliability 
is 0.51. Reference values for the Polish paediatric 
population aged > 11 years were developed for this 
questionnaire. Our results were compared with 
the reference values for healthy peers.
In our study, we evaluated results obtained us-
ing the Kidscreen-52 questionnaire and the SEG 
and KompOs scales. We also developed a  ques-
tionnaire that included items related to the previ-
ous disease course, treatment used, patient edu-
cation, and family situation to evaluate the effect 
of these factors on HRQoL in children with IgAN.
Statistical analysis
Normal distribution of  the  variables was eva-
luated using the Shapiro-Wilk and Lilliefors tests. 
Normally distributed data were shown as mean 
values ± standard deviation (SD), and non-normal-
ly distributed data were shown as medians and 
ranges. Statistical analysis included the  Student 
t test and linear regression. P < 0.05 was consid-
ered statistically significant. Analyses were per-
formed using the Statistica 9.0 software (StatSoft).
Results
The study group included 32 boys and 19 girls 
at the mean age of 14.54 ±3.69 years. The mean 
duration since the  diagnosis of  IgAN was 4.98 
±3.9 years (0.8–10.3), significantly longer in girls 
(6.58 ±4.2 vs. 4.03 ±3.40 years, p < 0.05). Clinical 
characteristics of  the study group are shown in 
Table I. Among children in the study group 4 had 
coexisting diseases – epilepsy in 1 patient, aller-
gy was diagnosed in 2 patients, arrythmia in 1, 
congenital heart defect in 1. Anthropome tric data 
of the study group revealed that mean BMI was 
21.87 kg/m2 (13.87–30.42), obesity was diagnosed 
in 8 patients and underweight in 2 children. 
Clinical manifestations of  IgAN included hae-
maturia with coexisting proteinuria in 39 (76.49%) 
patients. Among them 26 children had macroscop-
ic and 13 microscopic haematuria. Isolated micro-
scopic haematuria was noted in 4 (7.8%) and isolat-
ed proteinuria in 6 (11.76%) children. In 3 patients 
(5.8%) IgA nephropathy manifested as nephritic 
syndrome with kidney injury. Hypertension was 
present in 12 (23.53%) children. Glucocorticoste-
roid therapy was used in 36 (70.59%) children, in-
cluding previous steroid therapy (3-month interval 
before the study time) in 36 (70.59%) children and 
current steroid therapy in 15 (29.41%) children. 
10 (19.61%) children were on immunosuppressive 
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therapy during the study time. Immunosuppressive 
medications used were: mycophenolate mofetil in 
2 children, azathioprine in 8 and cyclosporine A in 
2 patients. Mean eGFR in the  study group was 
107.25 ml/min/1.73 m2 (48.8–178.97). Decreased 
eGFR (< 90 ml/min/1.73 m2) was found in 6 chil-
dren (11.76%).
Of 51 children in the study group, 29 (56.86%) 
resided in an urban area and 22 (43.14%) resided 
in a rural area. Due to renal disease and its treat-
ment, 7 of 51 children required an individualized 
education programme. Immediate household 
care was most commonly provided by the mother 
(37 children), and less frequently by both the 
mother and father (8 children), the father (one 
child), or grandparents (one child; no response 
to this question was provided in the  remain-
ing cases). Paid employment was reported by 
66% of caretakers, and 34% were not working.
The results of the Kidscreen-52 questionnaire, 
evaluating HRQoL, are shown in Table II. We found 
that physical wellbeing in children with IgAN was 
rated worse (p < 0.005) in comparison to healthy 
peers. Both boys and girls with IgAN also rat-
ed their psychological wellbeing as significantly 
worse compared to reference values in boys and 
girls (p < 0.05). The dimensions of self-perception 
and social support and peers were rated signifi-
cantly worse by boys in the study group compared 
to the population reference values. Social accep-
tance was rated higher in children with IgAN than 
in healthy peers; the  difference was statistically 
significant among girls.
Financial resources in the study group were rat-
ed as significantly higher compared to the popula-
tion reference values. 
Among manifestations of  IgAN, a  significant 
effect of  proteinuria on HRQoL was found. The 
presence of  proteinuria was associated with sig-
nificantly worse physical wellbeing as evaluated 
using the Kidscreen-52 questionnaire compared to 
the absence of proteinuria (58.72 ±18.45 vs. 74.44 
±22.97; p  < 0.05). The presence of  erythrocyturia 
and hypertension had no effect on HRQoL. Analy-
sis of the treatment effect on HRQoL showed that 
current steroid therapy and treatment with aza-
thioprine or cyclophosphamide (within the  last 
3 months) had no effect on various dimensions 
of  HRQoL in the  study group. No correlation was 
found with HRQoL and patients’ age or duration of 
the disease. 
No significant differences were found when the 
results of  the  Kidscreen-52 questionnaire were 
compared between urban and rural area residents 
(Table III). 
We found no effect of  the  education mode 
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tion reference values. We found a  positive cor-
relation between the KompOs subscale A  score 
(strength to initiate actions) and relations with 
parents (r = 0.32, p < 0.05) and school environ-
ment (r = 0.29, p < 0.05) dimensions of the Kid-
screen-52 questionnaire.
Using the SEG scale (in 46 children older than 
11 years), we observed high intensity of expressed 
anger in 9 (19.56%) children in the study group, 
moderate intensity in 9 (19.56%) children, and 
low intensity in 28 (60.88%) children (Table V). 
High intensity of suppressed anger was observed 
in 27 (58.70%) children in the study group, mod-
erate intensity in 13 (28.26%) children, and low 
intensity in 6 (13.04%) children. Compared to 
Evaluation using the KompOs scale (Table IV) 
was carried out in 46 children from the  study 
group  >  11 years of  age and showed that per-
ceived personal competence was rated high by 
23 (50%) children in the study group, moderate 
by 14 (30.44%) children, and low by 9 (19.56%) 
children. Compared to the  population reference 
values, children with IgAN were characterized 
by significantly higher perceived strength, which 
was shown in the overall study group and among 
boys. Perceived strength was also higher among 
urban area residents in the  study group com-
pared to the  reference values for urban area 
residents. Perceived persistence in the  study 
group did not differ compared to the  popula-
Table III. Kidscreen-52 questionnaire findings in relation to the place of residence
Parameter Urban area Rural area P-value
Mean ± SD
Physical well-being 63.28 ±20.41 62.27 ±20.51 NS
Psychological well-being 67.53 ±17.12 65.91 ±21.31 NS
Overall mood 75.86 ±16.85 79.22 ±17.55 NS
Self-perception 69.48 ±20.28 70.00 ±23.95 NS
Leisure time – autonomy 66.21 ±18.93 70.00 ±21.27 NS
Relations with parents 77.16 ±18.42 79.73 ±20.38 NS
Financial resources 66.09 ±30.04 73.86 ±26.14 NS
Social support and peers 63.22 ±21.01 62.50 ±26.26 NS
School environment 60.78 ±20.18 65.91 ±21.88 NS
Social acceptance 90.52 ±20.50 93.18 ±9.84 NS
Table IV. Personal competence (KompOs) scale findings
Parameter Overall 
score
Subscale A –  
perceived 
strength
Subscale B – 
perceived 
persistence




Study group, n = 46 36.38 ±7.54 18.98 ±4.041 17.40 ±4.52 < 0.05
Reference group – 17.09 ±3.251 16.93 ±3.15
Study group – boys, n = 28 38.04 ±5.64 19.81 ±3.222 17.53 ±4.77 < 0.05
Reference group – boys 34.04 ±5.04 17.44 ±3.212 16.6 ±3.23
Study group – girls, n = 18 34.11 ±6.59 17.83 ±3.42 16.28 ±4.27 NS
Reference group – girls 34.00 ±5.10 16.74 ±3.29 17.26 ±3.07
Study group – rural area residents, n = 20 36.20 ±6.76 19.20 ±4.11 17.00 ±4.24 NS
Reference group – rural area residents 34.73 ±4.83 17.34 ±2.91 17.39 ±3.21
Study group – urban area residents, n = 26 36.68 ±5.99 18.88 ±2.803 17.80 ±4.06 < 0.05
Reference group – urban area residents 33.63 ±5.1 16.68 ±3.673 16.92 ±3.01
1P < 0.05 – perceived strength in study group vs reference group. 2P < 0.05 – perceived strength in boys from study group vs. boys from 
reference group. 3P < 0.05 – perceived strength in urban area residents from study group vs. urban area residents from reference group.
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the  reference values, children with IgAN were 
characterized by a  significantly lower intensity 
of expressed anger (p < 0.001) and a significantly 
higher intensity of suppressed anger (p < 0.01).
These relations were found for both urban and 
rural area residents. We also found that the seve-
rity of expressed anger correlated negatively with 
relations with parents (r  =  –0.38, p  <  0.05) and 
school environment (r = –0.34, p < 0.05) dimen-
sions of  the Kidscreen-52 questionnaire. The se-
verity of  expressed anger also showed negative 
correlations with both subscales of  the KompOs 
scale, i.e. perceived strength (subscale A: r = –0.32; 
p < 0.05), and perceived persistence (subscale B: 
r = –0.38; p < 0.05).
Discussion
Previous studies on quality of  life in patients 
with renal disease focused on patients with ESRD, 
treated with dialysis therapy, or following kidney 
transplantation [5–8]. We are aware of two studies 
that evaluated HRQoL in children with less severe 
(stage 2–4) chronic kidney disease (CKD) [5, 9], 
including one in the  Polish population [5]. A  few 
studies concerned the  HRQOL in children with 
nephrotic syndrome [10, 11] or chronic glomeru-
lonephritis [12]. Our study is the first to evaluate 
HRQoL in a  homogeneous paediatric population 
with IgAN. We studied patients from 7 paediatric 
nephrology centres in Poland, and thus this group 
may be considered representative for the  Polish 
population of children with IgAN.
We used the  Kidscreen-52 questionnaire to 
evaluate HRQoL as it is a universal tool that con-
forms to high methodological standards. It is the 
only tool with reference values available for the 
Polish population, as it has been validated in 
a representative population of 1718 Polish children 
aged 8–18 years [2].
We found significantly worse psychological 
wellbeing in our study group compared to healthy 
peers. This is an important finding in the context 
of normal renal function in nearly all studied chil-
dren, as it indicates that quality of life in children 
with kidney disease is reduced prior to the diag-
nosis of  renal failure. Significantly worse HRQoL 
in regard to physical and mental functioning com-
pared to healthy peers has already been observed 
in children with ESRD [6]. In this population, it 
tended to be worse among patients treated with 
dialysis therapy compared to those after kidney 
transplantation or managed medically [5, 6]. Also 
in studies that evaluated HRQoL in children with 
stage 2–4 CKD, quality of  life in children with 
the  disease was significantly worse compared 
to healthy children. In addition, Gerson et al. re-
ported that HRQoL was not related to glomerular 
filtration rate, and no differences in HRQoL were 
found between stages 2–4 of  CKD [9]. Reduced 
psychological wellbeing in our patients may be 
caused by the  consciousness of  chronic disease, 
which may lead to the  necessity of  dialysis in 
the future, and significantly influence the lifestyle. 
The other important factor causing reduced psy-
chological wellbeing is isolation from colleagues 
as a result of hospitalizations. 
Physical wellbeing was rated significantly 
worse in boys with IgAN in comparison to healthy 
peers. A similar tendency was noted among girls, 
but probably because of the small number of girls 
Table V. Anger Expression Scale (SEG) findings
Parameter Expressed anger Suppressed anger P in comparison to 
reference values
Mean ± SD
Study group, n = 46 24.11 ±7.491 32.19 ±6.642 < 0.0011; < 0.0012
Reference group 27.65 ±6.811 28.06 ±7.072
Study group – boys, n = 28 23.04 ±7.21 32.57 ±6.64 NS
Reference group – boys 27.61 ±6.82 28.35 ±7.07
Study group – girls, n = 18 25.78 ±7.84 31.61 ±6.79 NS
Reference group – girls 27.68 ±6.08 27.31 ±7.09
Study group – rural area residents, n = 20 24.47 ±7.873 32.95 ±6.404 < 0.053; < 0.014
Reference group – rural area residents 27.27 ±6.483 27.14 ±6.414
Study group – urban area residents, n = 26 24.38 ±6.965 32.42 ±5.756 < 0.055; < 0.016
Reference group – urban area residents 27.8 ±6.485 28.40 ±7.286
1Expressed anger in study group vs. reference group p < 0.001. 2Suppresed anger in study group vs. reference group p < 0.05. 3Expressed 
anger in study group (rural area residents) vs. reference group from rural area p < 0.05. 4Suppressed anger in study group (rural area 
residents) vs. reference group from rural area p < 0.01. 5Expressed anger in study group (urban area residents) vs. reference group from 
urban area p < 0.05. 6Suppresed anger in study group (urban area residents) vs. reference group from urban area p < 0.01.
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enrolled in the study, the difference was not sta-
tistically significant. Worse physical wellbeing in 
patients with IgAN can be caused by symptoms 
of  the  disease such as oedema, episodes of  re-
current haematuria, as well as adverse effects 
of  pharmacotherapy such as overweight, weak-
ness, and susceptibility to infections.
Gerson et al. found that in children, older age 
and longer disease duration correlated with better 
overall HRQoL. This is probably connected with ed-
ucation concerning dealing with chronic disease. 
In our study duration of the disease and patients’ 
age had no effect on HRQoL [9].
In our study, more negative scores in specific 
dimensions of HRQoL in comparison to reference 
ranges were noted in boys. Boys were also char-
acterized by worse perceived physical wellbeing, 
self-perception, and relations with peers. This 
may be related to reduced participation in peer 
activities, sport activities and competitions, and 
increased school absence. Similarly, Quist et al. in 
a  study that evaluated quality of  life in children 
after kidney transplantation found worse somatic 
complaints and increased social problems (peers, 
school, hobbies) in boys compared to healthy 
peers [13]. In our study group, quality of life might 
have been reduced due to the treatment used and 
associated adverse effects such as body weight 
increase and short stature, related mostly to ste-
roid therapy. In a  study that evaluated quality 
of life in children with steroid-sensitive nephrotic 
syndrome, which was primarily treated with ste-
roids, reduced quality of  life in regard to social 
functioning was found [14]. Similarly, a negative 
effect on quality of life was found in children with 
other chronic diseases who required glucocorti-
costeroid therapy, such as asthma and haemato-
logical disorders [15, 16]. In our study group with 
IgAN, analysis of  the  treatment effect on HRQoL 
showed that current steroid therapy had no effect 
on various dimensions of HRQoL. In children with 
IgAN glucocorticosteroid therapy doses are lower 
than used in hematologic disorders, adverse ef-
fects may be less significant and the  impact on 
QoL may be smaller.
In addition, awareness of a chronic disease it-
self is a major psychological burden regardless of 
the disease severity. 
The lack of statistical significance of differences 
between results scored by girls with IgAN in com-
parison to the reference ranges may be caused by 
the small number of girls enrolled in the study.
We found no effect of the mode of education 
(individualized vs. regular schooling) on the eval-
uated HRQoL dimensions. This might have been 
related to the small size of the study sample.
No effect of the area of residence (rural vs. ur-
ban) was found on HRQoL. This is a positive fact, 
which may be connected with similar conditions 
of  living, advances in communicate technology 
and sufficient access to health care, which causes 
that burden caused by the disease does not cause 
differences in quality of life between children from 
different areas. Similarly, Kiliś-Pstrusińska, who 
evaluated a  population of  Polish children with 
stage 2–3 CKD, found no differences in quality 
of life in relation to social environment, gender, or 
age [5]. 
Literature data indicate that perceived person-
al competence is a  major factor affecting quality 
of  life, self-perception, and health-related be-
haviours. High perceived personal competence and 
control over unpleasant life events reduce emo-
tional excitement and increase readiness to par-
ry threats, thus helping to cope [17]. In our study 
group, as many as half of  the  patients declared 
high perceived personal competence, and 27.45% 
rated it as moderate. In the  study by Silva et al. 
[18], a high level of perceived personal competence 
correlated positively with compliance with chron-
ic immunosuppressive therapy following kidney 
transplantation. A similar relation was reported by 
Alatawi et al. in a group of patients with diabetes 
type 2 who required chronic drug therapy [19].
Both overexpressed anger and a  strong ten-
dency to suppress anger have an adverse health 
effect. Anger expression, which begins to devel-
op already in the pre-school age, is an established 
factor affecting cardiovascular disease risk, and 
chronically suppressed anger may underlie psy-
chosomatic disorders [20]. In our study group, we 
found a clear trend to suppress anger compared 
to the healthy population. The importance of such 
behaviour is not clear in patients with IgAN, but 
we might expect its influence on patients’ compli-
ance as a tendency to suppress emotions favours 
communication problems. Similar behaviours 
in patients with chronic disease were reported 
by Phipps et al. [21], who concluded that anger 
suppression is typical for children with chronic 
disease. However, anger suppression predisposes 
to non-adherence behaviours, and thus it is im-
portant to identify it in clinical practice using such 
tools as the SEG scale. 
In conclusion, we found lower HRQoL in regard 
to physical and psychological wellbeing in a group 
of Polish children with IgAN compared to healthy 
peers. These findings suggest that HRQoL should 
be monitored in this patient group, and clinicians 
should address these issues as an indicator of ef-
fective care. Measures should also be taken to 
improve HRQoL in this patient group, including 
provision of psychological care.
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